Actualités Reunion Neuroscience Inc - REUN | Actions Toronto Stock Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference

MORRISTOWN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a venture backed...

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

TORONTO, March 27, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or...

Reunion Neuroscience Files Lawsuit Against Mindset Pharma

TORONTO, March 13, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or...

Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

TORONTO, March 07, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or...

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Company Completed Phase 1 Interim Data Analysis for Lead Asset, RE104, Which Showed Strong Safety and...

Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ET

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or...

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or...

Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104

TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ: REUN, TSX: REUN) (“Reunion” or...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Reunion Neuroscience Inc (REUN)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

REUN Actualités

Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

Reunion Neuroscience Files Lawsuit Against Mindset Pharma

Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ET

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104

Reunion Neuroscience Inc. Provides 2023 Corporate Update

Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences in December

Reunion Neuroscience Puts in Place At-The-Market Equity Facility

Reunion Neuroscience Inc. Provides Business Update and Reports Fiscal Second Quarter 2023 Financial Results

Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET

Reunion Neuroscience to Present at Upcoming November Conferences

Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Reunion Neuroscience Inc (REUN) Actualités

Reunion Neuroscience Inc (REUN)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

REUN Actualités

Reunion Neuroscience Inc. Announces Upcoming Presentations at the Anxiety and Depression Association of America (ADAA) 2024 Conference

Reunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting

Reunion Neuroscience Files Lawsuit Against Mindset Pharma

Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference

Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results

Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ET

Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer

Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104

Reunion Neuroscience Inc. Provides 2023 Corporate Update

Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences in December

Reunion Neuroscience Puts in Place At-The-Market Equity Facility

Reunion Neuroscience Inc. Provides Business Update and Reports Fiscal Second Quarter 2023 Financial Results

Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET

Reunion Neuroscience to Present at Upcoming November Conferences

Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités